Bendrat K, Al-Abed Y, Callaway D J, Peng T, Calandra T, Metz C N, Bucala R
The Picower Institute for Medical Research, 350 Community Drive, Manhasset, New York 11030, USA.
Biochemistry. 1997 Dec 9;36(49):15356-62. doi: 10.1021/bi971153a.
The protein mediator MIF has been identified as being released from immune cells by glucocorticoid stimulation and to counter-regulate glucocorticoid action. MIF also has been described recently to exhibit dopachrome tautomerase activity and to be structurally homologous to the bacterial enzymes 4-oxalocrotonate tautomerase (4-OT) and 5-carboxymethyl-2-hydroxymuconate isomerase (CHMI). We performed site-directed mutagenesis and biochemical analyses of mouse MIF in order to identify amino acid residues and protein domains that are essential for enzymatic reactivity. Mutant proteins which lacked a free N-terminal proline residue were enzymatically inactive, as was a preparation of native MIF modified covalently at its N terminus by 3-bromopyruvate, suggesting that this proline has a catalytic function. Substitutions of the internal histidine residues 42 and 63 did not affect enzymatic activity, indicating that these basic residues are not involved in dopachrome tautomerization. Carboxy-truncated forms of MIF (residues 1-110 and 1-104) also were inactive, affirming the role of the carboxy terminus in stable trimer formation and the importance of the trimer for enzymatic activity. Additional evidence for the homotrimeric structure of MIF under native solution conditions was obtained by SDS-PAGE analysis of MIF after chemical cross-linking at low protein concentrations. The enzymatic activity of MIF was found to be reversibly inhibited by micromolar concentrations of fatty acids with chain lengths of at least 16 carbon atoms. Of note, molecular modeling of the substrate L-dopachrome methyl ester into the active site of MIF suggests an acid-catalyzed enzymatic mechanism that is different from that deduced from studies of the enzymes 4-OT and CHMI. Finally, in vitro analysis of an enzymatically inactive MIF species (P2 --> S) indicates that the glucocorticoid counter-regulatory activity of MIF can be functionally dissociated from its tautomerization activity.
蛋白介质巨噬细胞移动抑制因子(MIF)已被确定可通过糖皮质激素刺激从免疫细胞中释放出来,并对糖皮质激素的作用进行反调节。最近还发现MIF具有多巴色素互变异构酶活性,且在结构上与细菌酶4-氧代巴豆酸互变异构酶(4-OT)和5-羧甲基-2-羟基粘康酸异构酶(CHMI)同源。我们对小鼠MIF进行了定点诱变和生化分析,以确定对酶活性至关重要的氨基酸残基和蛋白质结构域。缺乏游离N端脯氨酸残基的突变蛋白无酶活性,用3-溴丙酮酸在其N端共价修饰的天然MIF制剂也是如此,这表明该脯氨酸具有催化功能。内部组氨酸残基42和63的取代不影响酶活性,表明这些碱性残基不参与多巴色素互变异构。MIF的羧基截短形式(残基1-110和1-104)也无活性,这证实了羧基末端在稳定三聚体形成中的作用以及三聚体对酶活性的重要性。通过在低蛋白浓度下对MIF进行化学交联后的SDS-PAGE分析,获得了天然溶液条件下MIF同源三聚体结构的额外证据。发现MIF的酶活性可被微摩尔浓度的链长至少为16个碳原子的脂肪酸可逆抑制。值得注意的是,将底物L-多巴色素甲酯分子建模到MIF的活性位点中,提示了一种酸催化的酶促机制,该机制不同于从对酶4-OT和CHMI的研究中推导出来的机制。最后,对一种无酶活性的MIF物种(P2→S)的体外分析表明,MIF的糖皮质激素反调节活性在功能上可与其互变异构活性分离。